This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
This regulatory milestone follows news from earlier this year, when the company announced positive verification study results for its Nellcor™ pulse oximetry system with Nell-EQ™ intelligent processor ...
The Nellcor pulse oximeter [Image courtesy of Medtronic] Medtronic (NYSE:MDT) announced today that it received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent ...
Good morning, and welcome to our fiscal '26 fourth quarter earnings webcast. I'm Ingrid Goldberg, Head of Medtronic Investor Relations. I'm joined by Geoff Martha, Chairman and Chief Executive Officer ...
In January, Medtronic published the results of a verification study of its new processor. Used across the full range of skin tones, the technology, Nell-EQ, achieved better oxygen saturation accuracy ...
The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results